Testing effectiveness (Phase 2)Study completedNCT00724009What this trial is testingClofarabine Bone Marrow CytoreductionWho this might be right forLeukemia University of Chicago 29
Testing effectiveness (Phase 2)Ended earlyNCT00069992What this trial is testingTotal-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes Baylor College of Medicine 7
Testing effectiveness (Phase 2)Ended earlyNCT00005641What this trial is testingRemoval of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171
Not applicableNot Yet RecruitingNCT07440654What this trial is testingEfficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With MyelofibrosisWho this might be right foraGVHD Prophylaxis Nanfang Hospital, Southern Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00024050What this trial is testingChemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07702578What this trial is testingT-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationWho this might be right forAMLMDS TScan Therapeutics, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT00002844What this trial is testingBone Marrow Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 49
Not applicableStudy completedNCT06267898What this trial is testingNon Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMMLWho this might be right forMDSCMML European Society for Blood and Marrow Transplantation 222
Testing effectiveness (Phase 2)Study completedNCT01541280What this trial is testingVIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome Nantes University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02752243What this trial is testingCIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.Who this might be right forMyelodysplastic SyndromesAcute Leukemia Peter Bader 32
Large-scale testing (Phase 3)Study completedNCT00330018What this trial is testingValganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)Who this might be right forBone Marrow TransplantationCytomegalovirus Hadassah Medical Organization 40
Large-scale testing (Phase 3)Study completedNCT01699412What this trial is testingClinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host DiseaseWho this might be right forGraft vs Host DiseaseOral Manifestations Grupo de Estudos Multicentricos em Onco-Hematologia 28
Testing effectiveness (Phase 2)Study completedNCT03961919What this trial is testingPhase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic TransplantWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesTransplant-Related Hematologic Malignancy Ciceri Fabio 15
Testing effectiveness (Phase 2)Ended earlyNCT00303719What this trial is testingAllogeneic Bone Marrow Transplantation Using Less Intensive TherapyWho this might be right forKidney CancerLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 342
Testing effectiveness (Phase 2)Looking for participantsNCT02579967What this trial is testingPilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesWho this might be right forPrimary T-cell Immunodeficiency DisordersCommon Variable ImmunodeficiencyImmune System Diseases+2 more National Cancer Institute (NCI) 354
Not applicableActive Not RecruitingNCT05236764What this trial is testingHaploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 DepletionWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more Baylor College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT02556931What this trial is testingShorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft MalignanciesWho this might be right forMyelodysplastic SyndromeChronic Myelomonocytic LeukemiaSmall Lymphocytic Lymphoma+11 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 117
Testing effectiveness (Phase 2)Ended earlyNCT00818961What this trial is testingDonor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Northside Hospital, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00997386What this trial is testingReduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure StatesWho this might be right forHematologic NeoplasmsMultiple MyelomaAnemia, Aplastic+2 more University of Arizona 16